Fulgent Genetics Inc Total Liabilities
Fulgent Genetics Inc total liabilities. Based on the latest financial reports, Fulgent Genetics Inc (FLGT) has total liabilities worth $93.24 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Fulgent Genetics Inc's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Fulgent Genetics Inc (2014–2025)
Total liabilities of Fulgent Genetics Inc from 2014 to 2025. This chart illustrates how Fulgent Genetics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore FLGT strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Fulgent Genetics Inc Competitors by Total Liabilities
The table below lists competitors of Fulgent Genetics Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Chong Kun Dang Pharmaceutical
KO:185750
|
Korea | ₩803.02 Billion |
|
Obrascon Huarte Lain SA
MC:OHLA
|
Spain | €2.84 Billion |
|
Hyundai Energy Solutions Co Ltd
KO:322000
|
Korea | ₩112.65 Billion |
|
Hainan Expressway Co Ltd
SHE:000886
|
China | CN¥1.14 Billion |
|
REGAL PARTNERS LTD.
F:OC7
|
Germany | €164.10 Million |
|
Shenandoah Telecommunications Co
NASDAQ:SHEN
|
USA | $995.92 Million |
|
Baiyang Aquatic Group Inc
SHE:002696
|
China | CN¥2.74 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down Fulgent Genetics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Fulgent Genetics Inc total assets.
Liquidity & Leverage Metrics
Fulgent Genetics Inc Total Liabilities Ratios Explained
Fulgent Genetics Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fulgent Genetics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fulgent Genetics Inc (2014–2025)
The table below shows the annual total liabilities of Fulgent Genetics Inc from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $106.81 Million | +17.63% |
| 2024-12-31 | $90.81 Million | -11.01% |
| 2023-12-31 | $102.04 Million | -12.17% |
| 2022-12-31 | $116.18 Million | +2.96% |
| 2021-12-31 | $112.84 Million | -13.91% |
| 2020-12-31 | $131.07 Million | +2092.24% |
| 2019-12-31 | $5.98 Million | +117.81% |
| 2018-12-31 | $2.75 Million | -6.15% |
| 2017-12-31 | $2.92 Million | -17.86% |
| 2016-12-31 | $3.56 Million | +419.10% |
| 2015-12-31 | $686.00K | +57.34% |
| 2014-12-31 | $436.00K | -- |
About Fulgent Genetics Inc
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pa… Read more